ASCO 2011: Breast cancer therapy could be guided with Nuvera's taxane test
This article was originally published in Clinica
Executive Summary
An assay developed by molecular diagnostics company Nuvera Biosciences can identify breast cancer patients likely to benefit from taxane therapy.